US2021017166A1PendingUtilityA1

Pharmacokinetically improved compounds

63
Assignee: SURFACE LOGIX LLCPriority: Mar 25, 2005Filed: Feb 24, 2020Published: Jan 21, 2021
Est. expiryMar 25, 2025(expired)· nominal 20-yr term from priority
C07D 419/00C07D 235/02C07D 239/72A61K 31/517C07D 405/14C07D 403/14A61P 15/10A61P 7/08C07D 403/12A61P 13/12A61P 25/28A61P 11/06A61P 25/00C07D 401/14C07D 413/14A61P 19/10A61P 35/00B82Y 30/00A61P 1/16A61P 27/06A61P 43/00A61P 25/08A61P 9/10A61P 25/02A61P 29/00A61P 9/12
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to inhibitors of ROCK1 and ROCK2 and methods of modulating the pharmacokinetic and/or pharmacodynamic properties of such compounds. Also provided are methods of inhibiting ROCK1 and or ROCK2 that are useful for the treatment of disease.

Claims

exact text as granted — not AI-modified
1 . A compound of formula I: 
       
         
           
           
               
               
           
         
         or pharmaceutically acceptable salt or hydrate thereof, wherein: 
         R 1  is selected from the group consisting of aryl, —(CH 2 ) y —NR 13 R 14 , —X—R 12 , —O—(CH 2 ) y —CO 2 R 12 , —O—(CH 2 ) y —C(═O)NR 13 R 14 , —O—(CH 2 ) y -heteroaryl, —O—(CH 2 ) y -cycloalkyl, —O—C(═O)—(CH 2 ) y —NR 13 R 14 , —O—(CH 2 ) z —NR 13 R 14 , —NH—C(═O)—(CH 2 ) y —NR 13 R 14 , —NH—C(═O)—X—R 15 , —NH—(CH 2 ) y —NR 13 R 14 ;
 R 12  is selected from the group consisting of C 1 -C 6  alkyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 16 R 17 , —(C 1 -C 6  alkyl)-C(═O)NR 16 R 17 , —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), aryl, aralkyl, heteroaryl, C 3 -C 7  cycloalkyl, a three to twelve membered heterocyclic ring containing up to 3 heteroatoms, each of which may be optionally substituted at one or more carbon atoms by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 R 13  and R 14  are independently selected from the group consisting of H, C 1 -C 8  alkyl, C 2 -C 8  alkenyl, C 2 -C 8  alkynyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 16 R 17 , —(C 1 -C 6  alkyl)-C(═O)NR 16 R 17 , aryl, aralkyl, heteroaryl, C 3 -C 7  cycloalkyl, a three to twelve membered heterocyclic ring containing up to 3 heteroatoms, each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 3 -C 7  cycloalkyl, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 or R 13  and R 14  may be taken together form a three to twelve membered heterocyclic ring having up to 3 heteroatoms which is optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, C 3 -C 7  cycloalkyl, oxo, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 X is selected from a covalent bond, O, NH, and C 1 -C 6  alkyl; 
 R 1  is selected from the group consisting of H, aryl, heteroaryl, C 3 -C 7  cycloalkyl, a three to twelve membered heterocyclic ring containing up to 3 heteroatoms, each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl, or R 15  is selected from —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 16 R 17 , —CO 2 R 18 , —O—(CH 2 ) x —CO 2 R 18 , and —C(═O)NR 16 R 17 ;
 R 16  and R 17  independently selected from the group consisting of H, C 1 -C 8  alkyl, C 2 -C 8  alkenyl, C 1 -C 8  alkynyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), aryl, aralkyl, heteroaryl, C 3 -C 7  cycloalkyl, a three to twelve membered heterocyclic ring containing up to 3 heteroatoms, each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 or R 16  and R 17  may be taken together form a three to twelve membered heterocyclic ring having up to 3 heteroatoms which is optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, oxo, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 R 18  is selected from the group consisting of H, aryl, aralkyl, heteroaryl, C 1 -C 6  alkyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 16 R 17 , —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoroalkyl; 
 
 x is selected from 0 to 6; 
 y is selected from 0 to 6; 
 z is selected from 2 to 6; 
 
         each R 2  is independently selected from the group consisting of lower alkyl, CN, halo, hydroxy, lower alkoxy, amino, and perfluoro lower alkyl; 
         each R 3  is independently selected from the group consisting of lower alkyl, CN, halo, hydroxy, lower alkoxy, amino, and perfluoro lower alkyl; 
         R 4  is selected from —(CH 2 ) a —NR 43 R 44 , —Y—R 42 , —O—(CH 2 ) a —CO 2 R 42 , —O—(CH 2 ) a —C(═O)NR 43 R 44 , —O—(CH 2 ) a -heteroaryl, —O—(CH 2 ) a -cycloalkyl, —O—C(═O)—(CH 2 ) a —NR 43 R 44 , —O—(CH 2 ) c —NR 43 R 44 , —NH—C(═O)—(CH 2 ) a —NR 43 R 44 , —NH—C(═O)—Y—R 45 , —NH—C(═O)—(CH 2 ) a —NR 43 R 44 ;
 R 42  is selected from the group consisting of C 1 -C 6  alkyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 46 R 47 , —(C 1 -C 6  alkyl)-C(═O)NR 46 R 47 , —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), each of which may be optionally substituted at one or more carbon atoms by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 R 43  and R 44  are independently selected from the group consisting of H, C 1 -C 8  alkyl, C 2 -C 8  alkenyl, C 1 -C 5  alkynyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 46 R 47 , —(C 1 -C 6  alkyl)-C(═O)NR 46 R 47 , aryl, aralkyl, heteroaryl, C 3 -C 7  cycloalkyl, a three to twelve membered heterocyclic ring containing up to 3 heteroatoms, each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 3 -C 7  cycloalkyl, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 or R 43  and R 44  may be taken together form a three to twelve membered heterocyclic ring having up to 3 heteroatoms which is optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, oxo, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 Y is selected from a covalent bond, O, NH, and C 1 -C 6  alkyl; 
 R 45  is selected from the group consisting of H, aryl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 46 R 47 , —CO 2 R 48 , —O—(CH 2 ) b —CO 2 R 48 , and —C(═O)NR 46 R 47 ,
 R 46  and R 47  independently selected from the group consisting of H, C 1 -C 8  alkyl, C 2 -C 8  alkenyl, C 1 -C 5  alkynyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), aryl, aralkyl, heteroaryl, C 3 -C 7  cycloalkyl, a three to twelve membered heterocyclic ring containing up to 3 heteroatoms, each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 or R 46  and R 47  may be taken together form a three to twelve membered heterocyclic ring having up to 3 heteroatoms which is optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, oxo, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 R 48  is selected from the group consisting of H, aryl, aralkyl, heteroaryl, C 1 -C 6  alkyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 46 R 47 , —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoroalkyl; 
 
 a is selected from 0 to 6; 
 b is selected from 0 to 6; 
 c is selected from 2 to 6; 
 
         R 5  is selected from the group consisting of H, C 1 -C 6  alkyl, —(CH 2 ) d —C(═O)—NR 53 R 54 , —C(═O)—(CH 2 ) d —NR 53 R 54 , —C(═O)—X—R 55 , and —C(═O)—(CH 2 ) d —NR 53 R 54 ;
 R 53  and R 54  are independently selected from the group consisting of H, C 1 -C 8  alkyl, C 2 -C 8  alkenyl, C 2 -C 8  alkynyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 56 R 57 , —(C 1 -C 6  alkyl)-C(═O)NR 56 R 57 , aryl, aralkyl, heteroaryl, C 3 -C 7  cycloalkyl, a three to twelve membered heterocyclic ring containing up to 3 heteroatoms, each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 3 -C 7  cycloalkyl, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 or R 53  and R 54  may be taken together form a three to twelve membered heterocyclic ring having up to 3 heteroatoms which is optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, C 3 -C 7  cycloalkyl, oxo, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 R 55  is selected from the group consisting of H, aryl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 56 R 57 , —CO 2 R 58 , —O—(CH 2 ) e —CO 2 R 58 , and —C(═O)NR 56 R 57 ,
 R 56  and R 57  independently selected from the group consisting of H, C 1 -C 8  alkyl, C 2 -C 8  alkenyl, C 1 -C 8  alkynyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), aryl, aralkyl, heteroaryl, C 3 -C 7  cycloalkyl, a three to twelve membered heterocyclic ring containing up to 3 heteroatoms, each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 
 or R 56  and R 57  may be taken together form a three to twelve membered heterocyclic ring having up to 3 heteroatoms which is optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, oxo, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 R 58  is selected from the group consisting of H, aryl, aralkyl, heteroaryl, C 1 -C 6  alkyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 56 R 57 , —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoroalkyl; 
 d is selected from 0 to 6; 
 e is selected from 0 to 6; 
 
         R 6  is selected from the group consisting of H, C 1 -C 6  alkyl, —(CH 2 ) r —C(═O)—NR 63 R 64 , —C(═O)—(CH 2 ) r —NR 63 R 64 , —C(═O)—X—R 65 , and —C(═O)—(CH 2 ) r —NR 63 R 64 ;
 R 63  and R 64  are independently selected from the group consisting of H, C 1 -C 8  alkyl, C 2 -C 8  alkenyl, C 2 -C 8  alkynyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 66 R 67 , —(C 1 -C 6  alkyl)-C(═O)NR 66 R 67 , aryl, aralkyl, heteroaryl, C 3 -C 7  cycloalkyl, a three to twelve membered heterocyclic ring containing up to 3 heteroatoms, each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 3 -C 7  cycloalkyl, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 or R 63  and R 64  may be taken together form a three to twelve membered heterocyclic ring having up to 3 heteroatoms which is optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, C 3 -C 7  cycloalkyl, oxo, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 R 65  is selected from the group consisting of H, aryl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 66 R 67 , —CO 2 R 68 , —O—(CH 2 ) s —CO 2 R 68 , and —C(═O)NR 66 R 67 ,
 R 66  and R 67  independently selected from the group consisting of H, C 1 -C 8  alkyl, C 2 -C 8  alkenyl, C 1 -C 8  alkynyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), aryl, aralkyl, heteroaryl, C 3 -C 7  cycloalkyl, a three to twelve membered heterocyclic ring containing up to 3 heteroatoms, each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 or R 66  and R 67  may be taken together form a three to twelve membered heterocyclic ring having up to 3 heteroatoms which is optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkyl, C 2 -C 6 , alkenyl, C 1 -C 6  alkoxy, oxo, hydroxy, amino, cyano and C 1 -C 3  perfluoro alkyl; 
 R 68  is selected from the group consisting of H, aryl, aralkyl, heteroaryl, C 1 -C 6  alkyl, —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), —(C 1 -C 6  alkyl)-NR 66 R 67 , —(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl)-O—(C 1 -C 6  alkyl), each of which may be optionally substituted by from 1 to 3 substituents independently selected from halo, C 1 -C 6  alkoxy, hydroxy, amino, cyano and C 1 -C 3  perfluoroalkyl; 
 r is selected from 0 to 6; 
 s is selected from 0 to 6; 
 
 
         n is selected from 0 to 4; 
         m is selected from 0 to 3; and 
         p is selected from 0 and 1. 
       
     
     
         2 - 26 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.